Invention Grant
- Patent Title: Treatment and sustained virologic remission of HIV infection by antibodies to CD4 in HAART stabilized patients
-
Application No.: US16325361Application Date: 2017-08-13
-
Publication No.: US11292839B2Publication Date: 2022-04-05
- Inventor: Chang Yi Wang
- Applicant: UBI US Holdings LLC
- Applicant Address: US NY Hauppauge
- Assignee: UBI US Holdings LLC
- Current Assignee: UBI US Holdings LLC
- Current Assignee Address: US NY Hauppauge
- Agency: Locke Lord LLP
- Agent Peter N. Fill; Nicholas J. DiCeglie, Jr.
- International Application: PCT/US2017/046668 WO 20170813
- International Announcement: WO2018/035001 WO 20180222
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K38/00 ; A61K38/17 ; A61K39/395 ; A61K45/06 ; C07K16/28 ; A61P31/18
Abstract:
The present disclosure is directed to compositions and methods for the prevention, treatment, and/or functional cure of HIV infection. One aspect of the present disclosure relates to monoclonal antibodies directed against CD4, compositions thereof, and methods employing such compositions for the prevention, treatment, and functional cure of HIV infection.
Public/Granted literature
Information query
